The Latin America, Middle East and Africa Sciatica Treatment Market should witness market growth of 9.5% CAGR during the forecast period (2022-2028).
Many types of pain may have varying degrees of severity, and various things can trigger them. Therefore, a more drastic course of action could be explored initially for certain patients. In general, however, if a six-week trial of conservative, self-care measures, such as cold, heat, stretching, and over-the-counter medications, hasn't yielded relief, it's time to go back to a doctor and try another course of action. Finding exercise motions that lessen sciatica by relieving pressure on the nerve is the aim of physical therapy.
A fitness regimen should include stretching activities to increase muscular flexibility and cardiovascular workouts (such as walking, swimming, and water aerobics). The medical professionals may suggest a physical therapist who will collaborate to create a stretching and aerobic exercise routine and other exercises to strengthen the legs, back, and belly muscles.
An anti-inflammatory drug called a corticosteroid injection into the lower back may help lessen the discomfort and swelling around the damaged nerve roots. Injections are administered as an outpatient therapy under local anesthetic and provide temporary pain relief (usually lasting up to three months). However, as the injection is being administered, patient may experience pressure and a burning or stinging sensation.
The UAE government has made building a top-notch healthcare infrastructure a primary priority; consequently, the industry has developed and grown tremendously over the last few years. According to the World Health Organization, one in five UAE adults and adults aged 18 and over are obese. These people, backed by relatively high-income levels, will need higher quality healthcare as the prevalence of lifestyle illnesses rises. Over 9.4 million people live in the UAE, and about 85% are foreigners. The UAE government is liberalizing its rules to increase foreign investment and raise the level of healthcare. To make Dubai a regional hub of superior healthcare, the UAE government intends to increase the number of medical tourists visiting the country. These factors will encourage the sciatica treatment market in the LAMEA region to develop.
The Brazil market dominated the LAMEA Sciatica Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $17,047 Thousands by 2028. The Argentina market is experiencing a CAGR of 10.1% during (2022-2028). Additionally, The UAE market would showcase a CAGR of 9.2% during (2022-2028).
Based on Type, the market is segmented into Chronic, Acute and Others. Based on Distribution Channel, the market is segmented into Retail & Specialty Pharmacies, Hospital Pharmacies and Online Providers. Based on Drug Class, the market is segmented into Non-Steroidal anti-inflammatory, Steroids, Antidepressants and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sorrento Therapeutics, Inc., Alkem Laboratories Ltd., Amneal Pharmaceuticals, Inc., Aurobindo Pharma Limited, Novartis AG, and Cadila Healthcare Ltd. (Zydus Cadila)
Many types of pain may have varying degrees of severity, and various things can trigger them. Therefore, a more drastic course of action could be explored initially for certain patients. In general, however, if a six-week trial of conservative, self-care measures, such as cold, heat, stretching, and over-the-counter medications, hasn't yielded relief, it's time to go back to a doctor and try another course of action. Finding exercise motions that lessen sciatica by relieving pressure on the nerve is the aim of physical therapy.
A fitness regimen should include stretching activities to increase muscular flexibility and cardiovascular workouts (such as walking, swimming, and water aerobics). The medical professionals may suggest a physical therapist who will collaborate to create a stretching and aerobic exercise routine and other exercises to strengthen the legs, back, and belly muscles.
An anti-inflammatory drug called a corticosteroid injection into the lower back may help lessen the discomfort and swelling around the damaged nerve roots. Injections are administered as an outpatient therapy under local anesthetic and provide temporary pain relief (usually lasting up to three months). However, as the injection is being administered, patient may experience pressure and a burning or stinging sensation.
The UAE government has made building a top-notch healthcare infrastructure a primary priority; consequently, the industry has developed and grown tremendously over the last few years. According to the World Health Organization, one in five UAE adults and adults aged 18 and over are obese. These people, backed by relatively high-income levels, will need higher quality healthcare as the prevalence of lifestyle illnesses rises. Over 9.4 million people live in the UAE, and about 85% are foreigners. The UAE government is liberalizing its rules to increase foreign investment and raise the level of healthcare. To make Dubai a regional hub of superior healthcare, the UAE government intends to increase the number of medical tourists visiting the country. These factors will encourage the sciatica treatment market in the LAMEA region to develop.
The Brazil market dominated the LAMEA Sciatica Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $17,047 Thousands by 2028. The Argentina market is experiencing a CAGR of 10.1% during (2022-2028). Additionally, The UAE market would showcase a CAGR of 9.2% during (2022-2028).
Based on Type, the market is segmented into Chronic, Acute and Others. Based on Distribution Channel, the market is segmented into Retail & Specialty Pharmacies, Hospital Pharmacies and Online Providers. Based on Drug Class, the market is segmented into Non-Steroidal anti-inflammatory, Steroids, Antidepressants and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sorrento Therapeutics, Inc., Alkem Laboratories Ltd., Amneal Pharmaceuticals, Inc., Aurobindo Pharma Limited, Novartis AG, and Cadila Healthcare Ltd. (Zydus Cadila)
Scope of the Study
By Type
- Chronic
- Acute
- Others
By Distribution Channel
- Retail & Specialty Pharmacies
- Hospital Pharmacies
- Online Providers
By Drug Class
- Non-Steroidal anti-inflammatory
- Steroids
- Antidepressants
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Johnson & Johnson
- Teva Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Sorrento Therapeutics, Inc.
- Alkem Laboratories Ltd.
- Amneal Pharmaceuticals, Inc.
- Aurobindo Pharma Limited
- Novartis AG
- Cadila Healthcare Ltd. (Zydus Cadila)
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Sciatica Treatment Market, by Type
1.4.2 LAMEA Sciatica Treatment Market, by Distribution Channel
1.4.3 LAMEA Sciatica Treatment Market, by Drug Class
1.4.4 LAMEA Sciatica Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Sciatica Treatment Market by Type
3.1 LAMEA Chronic Market by Country
3.2 LAMEA Acute Market by Country
3.3 LAMEA Others Market by Country
Chapter 4. LAMEA Sciatica Treatment Market by Distribution Channel
4.1 LAMEA Retail & Specialty Pharmacies Market by Country
4.2 LAMEA Hospital Pharmacies Market by Country
4.3 LAMEA Online Providers Market by Country
Chapter 5. LAMEA Sciatica Treatment Market by Drug Class
5.1 LAMEA Non-Steroidal anti-inflammatory Market by Country
5.2 LAMEA Steroids Market by Country
5.3 LAMEA Antidepressants Market by Country
5.4 LAMEA Others Market by Country
Chapter 6. LAMEA Sciatica Treatment Market by Country
6.1 Brazil Sciatica Treatment Market
6.1.1 Brazil Sciatica Treatment Market by Type
6.1.2 Brazil Sciatica Treatment Market by Distribution Channel
6.1.3 Brazil Sciatica Treatment Market by Drug Class
6.2 Argentina Sciatica Treatment Market
6.2.1 Argentina Sciatica Treatment Market by Type
6.2.2 Argentina Sciatica Treatment Market by Distribution Channel
6.2.3 Argentina Sciatica Treatment Market by Drug Class
6.3 UAE Sciatica Treatment Market
6.3.1 UAE Sciatica Treatment Market by Type
6.3.2 UAE Sciatica Treatment Market by Distribution Channel
6.3.3 UAE Sciatica Treatment Market by Drug Class
6.4 Saudi Arabia Sciatica Treatment Market
6.4.1 Saudi Arabia Sciatica Treatment Market by Type
6.4.2 Saudi Arabia Sciatica Treatment Market by Distribution Channel
6.4.3 Saudi Arabia Sciatica Treatment Market by Drug Class
6.5 South Africa Sciatica Treatment Market
6.5.1 South Africa Sciatica Treatment Market by Type
6.5.2 South Africa Sciatica Treatment Market by Distribution Channel
6.5.3 South Africa Sciatica Treatment Market by Drug Class
6.6 Nigeria Sciatica Treatment Market
6.6.1 Nigeria Sciatica Treatment Market by Type
6.6.2 Nigeria Sciatica Treatment Market by Distribution Channel
6.6.3 Nigeria Sciatica Treatment Market by Drug Class
6.7 Rest of LAMEA Sciatica Treatment Market
6.7.1 Rest of LAMEA Sciatica Treatment Market by Type
6.7.2 Rest of LAMEA Sciatica Treatment Market by Distribution Channel
6.7.3 Rest of LAMEA Sciatica Treatment Market by Drug Class
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Johnson & Johnson
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental &Regional Analysis
7.2.4 Research & Development Expenses
7.3 Teva Pharmaceutical Industries Ltd.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.4 Sun Pharmaceutical Industries Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional & Segmental Analysis
7.4.4 Research & Development Expenses
7.5 Sorrento Therapeutics, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental Analysis
7.5.4 Research & Development Expenses
7.6 Alkem Laboratories Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.7 Amneal Pharmaceuticals, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental
7.7.4 Research & Development Expenses
7.8 Aurobindo Pharma Limited
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.9 Novartis AG
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.10. Cadila Healthcare Ltd. (Zydus Cadila)
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
Companies Mentioned
- Abbott Laboratories
- Johnson & Johnson
- Teva Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Sorrento Therapeutics, Inc.
- Alkem Laboratories Ltd.
- Amneal Pharmaceuticals, Inc.
- Aurobindo Pharma Limited
- Novartis AG
- Cadila Healthcare Ltd. (Zydus Cadila)
Methodology
LOADING...
